product summary
company name :
Developmental Studies Hybridoma Bank
product type :
antibody
product name :
PTEN/ Phosphatase And Tensin Homolog Peptide 1
catalog :
CPTC-PTEN-3
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
CPTC-PTEN-3
reactivity :
human
more info or order :
product information
Internal ID :
26007
Name :
CPTC-PTEN-3
Depositor Name :
Clinical Proteomics Technologies for Cancer
Depositor Institution :
National Cancer Institute
Depositor Website :
http://proteomics.cancer.gov/
Date Deposited :
6/14/16
Allow Hybridoma Distribution :
No
Cells Available (legacy) :
No
Antigen :
PTEN/ Phosphatase And Tensin Homolog Peptide 1
Antigen Species :
Human
Host Species :
mouse
Isotype :
MIgG3, kappa light chain
Positive Tested Species Reactivity :
Human
Depositor Notes (Special Instructions) :
This antigen is a tumor suppressor also known as Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN.
Collections :
Enzymes,Human
Search Keywords :
Clinical Proteomics Technologies for Cancer, PTEN/ Phosphatase And Tensin Homolog , Human, MIgG3, kappa light chain, Human, PTEN, BZS, MHAM, MMAC1, PTEN1, TEP1, , Monoclonal, Human/Enzymes,
Antigen Molecular Weight :
47.1 kDa
Gene :
PTEN
Alternate Gene Name(s) :
BZS, MHAM, MMAC1, PTEN1, TEP1
Uniprot ID :
P60484
Antibody Registry ID :
AB_2722095
Immunogen :
Synthetic Peptide
Immunogen Sequence :
IYNLCAER
Clonality :
Monoclonal
Myeloma Strain :
p3x63Ag8.653
Epitope Mapped :
Yes
Epitope Location or Sequence :
a.a. 67-74
Additional Information :
RRID:AB_2722095
Additional Characterization :
https://antibodies.cancer.gov/apps/site
/detail/Phosphatase%20And%20Tensin%20Ho
molog%20Peptide%201#Phosphatase_And_Ten
sin_Homolog_Peptide_1
/detail/Phosphatase%20And%20Tensin%20Ho
molog%20Peptide%201#Phosphatase_And_Ten
sin_Homolog_Peptide_1
DSHB Growth Medium :
Iscove's
more info or order :
company information
Developmental Studies Hybridoma Bank
review
product type
related products
browse more products
questions and comments